Achillion Pharmaceuticals Inc
Pharmaceutical company · New Haven, Connecticut, United States
Achillion Pharmaceuticals Inc is a pharmaceutical company headquartered in New Haven, Connecticut, United States. It has received 2 US government small-business research awards (SBIR/STTR) from health agencies, $897,665 in total, most recently in 2010. It has reported private securities offerings to the US SEC, most recently $50 million sold in a notice filed in 2010.
Achillion Pharmaceuticals at a glance
What does Achillion Pharmaceuticals do?
US government research funding
2 SBIR/STTR small-business research awards from US health agencies, $897,665 in total (2005 to 2010).
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $50.1 million sold (2010).
Frequently asked questions about Achillion Pharmaceuticals
Where is Achillion Pharmaceuticals headquartered?
Achillion Pharmaceuticals Inc is headquartered in New Haven, Connecticut, United States.
What does Achillion Pharmaceuticals do?
Achillion Pharmaceuticals Inc is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Similar companies
- Arvinas, Inc.New Haven, Connecticut, United States
- Yarrow Bioscience, Inc.New Haven, Connecticut, United States
- Trevi Therapeutics, Inc.New Haven, Connecticut, United States
- Veradermics, IncNew Haven, Connecticut, United States
- Rallybio CorpNew Haven, Connecticut, United States
- Biohaven Ltd.New Haven, Connecticut, United States
- BioXcel Therapeutics, Inc.New Haven, Connecticut, United States
- Biohaven Pharmaceutical Holding Co Ltd.New Haven, Connecticut, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences